|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1539592
|
|
Name of medicinal product:
|
Nobivac Myxo-RHD
|
|
Active substances:
|
|
|
ATC code:
|
QI08AD02
|
|
Dosage form:
|
lyophilisate and solvent for suspension for injection
|
|
Route of administration:
|
subcutaneous use
|
|
Strengh:
|
|
|
Amount in package:
|
50annus 10TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
lahusti 50 ml
|
|
Indication:
|
For active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease (RHD) caused by classical RHD virus strains.
Onset of immunity: 3 weeks.
Duration of immunity: 1 year.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Withdrawal time:
|
0 päeva
|
|
Species:
|
küülik
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
Intervet International B.V.
|
|
Marketing authorization number:
|
EU/2/11/132
|
|
Marketing authorization issued on:
|
September 7, 2011
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
Entry/Changing date:
August 26, 2016
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere